BRIEF—BeiGene appoints new China chief and company president

China and USA-based oncology specialist BeiGene has appointed Xiaobin Wu as general manager of China and president of the company, reporting to the CEO.

Dr Wu joins BeiGene from Pfizer China, where he served as country manager since 2009, expanding the firm’s portfolio and organization. He has previously headed up both Wyeth and Bayer’s Chinese operations.

BeiGene chief exec John Oyler commented: “Dr Wu has a track record of repeatedly building and operating successful organizations in China.”

“His strong leadership has allowed him to build exceptional teams, launch impactful patient therapies, and drive outstanding results for these organizations; all of which will be critical to helping BeiGene reach the next stage in its growth.”